Instil Bio, Inc.

TIL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$13,587-$21,394-$28,200-$11,895
Dep. & Amort.$12$12$498$741
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1,824$3,495$4,501
Change in WC$741-$5,048$3,619-$4,074
Other Non-Cash$2,277$9,815$16,393$168
Operating Cash Flow-$10,557-$14,791-$4,195-$10,559
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$5$0$405$0
Inv. Purchases-$6,558-$38,713-$38,194-$27,325
Inv. Sales/Matur.$25,000$38,300$47,400$40,005
Other Inv. Act.-$10,000$13$0$320
Investing Cash Flow$8,447-$400$9,611$13,000
Financing Activities
Debt Repay.$0$0$0$2,762
Stock Issued$378$0$404$206
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$6,682-$172-$1,372
Financing Cash Flow$378$6,682$232$1,596
Forex Effect-$25$21$43-$65
Net Chg. in Cash-$1,757-$8,488$5,691$3,972
Supplemental Information
Beg. Cash$7,838$16,326$10,635$6,663
End Cash$6,081$7,838$16,326$10,635
Free Cash Flow-$10,557-$14,791-$4,195-$10,559
Instil Bio, Inc. (TIL) Financial Statements & Key Stats | AlphaPilot